CX-3002
N/A
Report date: 2024/12/28 20:00:07
NME
Base Information
Drug NameCX-3002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChengdu Easton Biopharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A